These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8667223

  • 1. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
    Cushing DJ, Zgombick JM, Nelson DL, Cohen ML.
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1560-6. PubMed ID: 8667223
    [Abstract] [Full Text] [Related]

  • 2. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ, Cohen ML.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [Abstract] [Full Text] [Related]

  • 3. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML, Robertson DW, Bloomquist WE, Wilson HC.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ, Cohen ML.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [Abstract] [Full Text] [Related]

  • 5. Serotonin-induced relaxation in canine coronary artery smooth muscle.
    Cushing DJ, Cohen ML.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):123-9. PubMed ID: 1403777
    [Abstract] [Full Text] [Related]

  • 6. The relaxant 5-HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5-ht7 receptor subtype.
    Terrón JA.
    Br J Pharmacol; 1996 Jul; 118(6):1421-8. PubMed ID: 8832067
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH, Milhahn H, Eich E.
    J Med Chem; 1999 Feb 25; 42(4):659-68. PubMed ID: 10052973
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries.
    Terrón JA, Falcón-Neri A.
    Br J Pharmacol; 1999 Jun 25; 127(3):609-16. PubMed ID: 10401550
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
    Prins NH, Akkermans LM, Lefebvre RA, Schuurkes JA.
    Br J Pharmacol; 2001 Nov 25; 134(6):1351-9. PubMed ID: 11704657
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle.
    Janssen P, Prins NH, Meulemans AL, Lefebvre RA.
    Br J Pharmacol; 2002 May 25; 136(2):321-9. PubMed ID: 12010782
    [Abstract] [Full Text] [Related]

  • 12. Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
    Kauffman RF, Bean JS, Bloomquist WE, Cohen ML.
    J Pharmacol Exp Ther; 1993 Jul 25; 266(1):450-5. PubMed ID: 8331571
    [Abstract] [Full Text] [Related]

  • 13. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
    Villalón CM, Heiligers JP, Centurión D, De Vries P, Saxena PR.
    Br J Pharmacol; 1997 Jul 25; 121(6):1187-95. PubMed ID: 9249256
    [Abstract] [Full Text] [Related]

  • 14. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
    Cohen ML, Colbert WE.
    J Pharmacol Exp Ther; 1986 Jun 25; 237(3):713-8. PubMed ID: 3712277
    [Abstract] [Full Text] [Related]

  • 15. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML, Fuller RW, Kurz KD, Parli CJ, Mason NR, Meyers DB, Smallwood JK, Toomey RE.
    J Pharmacol Exp Ther; 1988 Jan 25; 244(1):106-12. PubMed ID: 3335993
    [Abstract] [Full Text] [Related]

  • 16. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
    Cohen ML, Parli CJ, Fuller RW.
    J Pharmacol Exp Ther; 1989 Dec 25; 251(3):1006-11. PubMed ID: 2600800
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
    Prins NH, Briejer MR, Schuurkes JA.
    Br J Pharmacol; 1997 Feb 25; 120(4):714-20. PubMed ID: 9051313
    [Abstract] [Full Text] [Related]

  • 18. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.
    Irving HR, Tan YY, Tochon-Danguy N, Liu H, Chetty N, Desmond PV, Pouton CW, Coupar IM.
    Life Sci; 2007 Mar 06; 80(13):1198-205. PubMed ID: 17258778
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW, Thompson JM.
    J Pharmacol Exp Ther; 2004 Apr 06; 309(1):165-72. PubMed ID: 14724222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.